These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 36631836)

  • 1. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment.
    Zhao H; Zhang J; Cheng X; Nie X; He B
    J Ovarian Res; 2023 Jan; 16(1):9. PubMed ID: 36631836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and hyperandrogenism in women with polycystic ovary syndrome.
    Baptiste CG; Battista MC; Trottier A; Baillargeon JP
    J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):42-52. PubMed ID: 20036327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
    Rosenfield RL; Ehrmann DA
    Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome.
    Sozen I; Arici A
    Obstet Gynecol Surv; 2000 May; 55(5):321-8. PubMed ID: 10804539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The latest reports and treatment methods on polycystic ovary syndrome.
    Stańczak NA; Grywalska E; Dudzińska E
    Ann Med; 2024 Dec; 56(1):2357737. PubMed ID: 38965663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
    Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
    Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hyperinsulinaemia and insulin resistance on endocrine, metabolic and fertility outcomes in women with polycystic ovary syndrome undergoing ovulation induction.
    Zhang D; Yang X; Li J; Yu J; Wu X
    Clin Endocrinol (Oxf); 2019 Sep; 91(3):440-448. PubMed ID: 31222771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance.
    Hernández-Jiménez JL; Barrera D; Espinoza-Simón E; González J; Ortíz-Hernández R; Escobar L; Echeverría O; Torres-Ramírez N
    Gynecol Endocrinol; 2022 Jan; 38(1):2-9. PubMed ID: 34787028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
    Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
    Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance.
    Herman R; Sikonja J; Jensterle M; Janez A; Dolzan V
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and polycystic ovary syndrome.
    Barber TM; Franks S
    Clin Endocrinol (Oxf); 2021 Oct; 95(4):531-541. PubMed ID: 33460482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women?
    Morgante G; Troìa L; De Leo V
    J Steroid Biochem Mol Biol; 2021 Jan; 205():105770. PubMed ID: 33065278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic Reticulum Stress: A New Research Direction for Polycystic Ovary Syndrome?
    Wang C; Zhang Y
    DNA Cell Biol; 2022 Apr; 41(4):356-367. PubMed ID: 35353637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
    Nestler JE
    Semin Reprod Endocrinol; 1997 May; 15(2):111-22. PubMed ID: 9165656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome.
    Ding H; Zhang J; Zhang F; Zhang S; Chen X; Liang W; Xie Q
    Front Endocrinol (Lausanne); 2021; 12():741764. PubMed ID: 34745009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes.
    Tosi F; Bonora E; Moghetti P
    Hum Reprod; 2017 Dec; 32(12):2515-2521. PubMed ID: 29040529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.